NASDAQ:SBRA - Get Free Report ) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.340-1.380 for the period, compared to the consensus estimate of 1.370. The company issued revenue guidance of -.
Get Sabra Health Care REIT alerts:
Sign Up
Wall Street Analyst Weigh In A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They set a buy rating and a $21.00 price target for the company. Wedbush reaffirmed an outperform rating and issued a $17.00 price target on shares of Sabra Health Care REIT in a report on Thursday, February 29th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and a consensus price target of $15.77.
View Our Latest Stock Report on Sabra Health Care REIT
Sabra Health Care REIT Price Performance SBRA stock traded up $0.13 during trading on Wednesday, hitting $14.87. The stock had a trading volume of 2,811,925 shares, compared to its average volume of 2,022,285. The company's 50-day moving average price is $14.12 and its two-hundred day moving average price is $14.03. Sabra Health Care REIT has a twelve month low of $10.30 and a twelve month high of $14.92. The stock has a market capitalization of $3.44 billion, a P/E ratio of 294.80, a PEG ratio of 5.15 and a beta of 1.17. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.41 and a quick ratio of 3.41.
About Sabra Health Care REIT (
Get Free Report )
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Further Reading This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
